Life Sciences

Welcome to HS Life Sciences
Menu Links
Path
contact-us
Link text
Contact Us
Path
about-us
Link text
About Us
Path
courses
Link text
Events
Footer Banner
Footer Contact Us

CONTACT US
Ruskin House, 40-41 Museum Street, London WC1A 1LT, UK

Footer Copyright Notice

Henry Stewart Conference Studies LLP is a limited liability partnership, registered in England, registration number OC334769 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events Ltd is a limited company, registered in England, registration number 06532399 with its registered office at 40-41 Museum Street, London WC1A 1LT. Henry Stewart Events, Inc. is a corporation incorporated in the State of Delaware, USA having a business office at PKF O’Connor Davies LLP, 665 Fifth Avenue, New York NY 10022.
© Henry Stewart Conference Studies LLP or its affiliates.

Display Name
HS Life Sciences
Banner Image

Life Sciences Webinar Speaker Anthony O'Hagan

Professor Anthony O'Hagan is an Emeritus Professor of Statistics at the University of Sheffield, UK.  A major strand of his research has been the elicitation of expert knowledge.  With Professor Jeremy Oakley (University of Sheffield), he developed the Sheffield Elicitation Framework (SHELF), now in version 4.  He has provided consultancy, training, and practical elicitations for several organisations in diverse sectors, including GlaxoSmithKline, Swiss Re and the European Food Safety Authority.

Events Life Sciences Getting the Big 'Go – No Go' Decisions Right: Harnessing the Power of Expert Knowledge Elicitation

Getting the Big ‘Go – No Go’ Decisions Right: Harnessing the Power of Expert Knowledge Elicitation

What Expert Knowledge Elicitation is
When to use it
How to do it well
⠀⠀⠀
Big decisions typically come with big risks. Expert Elicitation can reduce the risks of making the wrong call. This is a webinar on when to do Expert Elicitation and how to do Expert Elicitation.

The need:

Life Sciences Hub Speaker Brian Tseng

Brian is a board-certified MD/PhD Pediatric Neurologist who has served in roles as a clinician, academic researcher, and vice-president in top biotech and healthcare companies. He has extensive experience leading teams of teams, coordinating and uniting large groups of people to successfully develop new pediatric medicines, including gene therapies.

Life Sciences Speaker Brian Tseng

Brian is a board-certified MD/PhD Pediatric Neurologist who has served in roles as a clinician, academic researcher, and vice-president in top biotech and healthcare companies. He has extensive experience leading teams of teams, coordinating and uniting large groups of people to successfully develop new pediatric medicines, including gene therapies.

Life Sciences Hub Speaker Darcy Forman

Darcy has responsibility and oversight for clinical operations service delivery, including patient engagement, clinical operations, data management, and nursing solutions, and she has more than 20 years of experience bridging clinical operational expertise and strategic corporate development initiatives with a passion for innovative and decentralized clinical trial execution.

Life Sciences Speaker Darcy Forman

Darcy has responsibility and oversight for clinical operations service delivery, including patient engagement, clinical operations, data management, and nursing solutions, and she has more than 20 years of experience bridging clinical operational expertise and strategic corporate development initiatives with a passion for innovative and decentralized clinical trial execution.

Life Sciences Hub Speaker Sam Hariry

Sam leads a team focused on modernising and adapting clinical trials and pharmaceutical operations. This includes areas such as adding technology to trials to bring better and more meaningful data; how we find and interact with patients in clinical research; how trials are run and where – in order to increase access and representation; as well as other aspects of patient centricity and trial decentralization.

Life Sciences Speaker Sam Hariry

Sam leads a team focused on modernising and adapting clinical trials and pharmaceutical operations. This includes areas such as adding technology to trials to bring better and more meaningful data; how we find and interact with patients in clinical research; how trials are run and where – in order to increase access and representation; as well as other aspects of patient centricity and trial decentralization.

Life Sciences Hub Speaker Sarah Hemsley

Sarah’s key focus is how do we design and execute better clinical trials, improving access and reducing burden for our patients? Sarah brings 19 years of experience to her role as an Innovation Project Manager in the Translational Medicine group within the Novartis Institutes for BioMedical Research (NIBR). She leads multiple innovative and novel trial technology projects, ranging from digital recruitment of trial subjects to novel data collection methods and looking at ways to better engage with patients during and after study participation.

Life Sciences